Evidence map›Paper›PMID 39804536›Full record

ArticleInsights into imaging2025

Automatic segmentation model and machine learning model grounded in ultrasound radiomics for distinguishing between low malignant risk and intermediate-high malignant risk of adnexal masses.

Lu Liu, Wenjun Cai, Feibo Zheng, Hongyan Tian, Yanping Li, Ting Wang, Xiaonan Chen, Wenjing Zhu

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. O-RADS for assessment of adnexal lesions: current status, challenges and future directions.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Review
  4. Review
  5. Radiomics and radiogenomics in ovarian cancer: a review with a focus on ultrasound applications.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lu LiuDepartment of Ultrasound Medicine, South China Hospital, Medical School, Shenzhen University, Shenzhen, P. R. China.
Wenjun CaiDepartment of Ultrasound, Shenzhen University General Hospital, Medical School, Shenzhen University, Shenzhen, P. R. China.
Feibo ZhengDepartment of Nuclear Medicine, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, P. R. China.
Hongyan TianDepartment of Ultrasound Medicine, South China Hospital, Medical School, Shenzhen University, Shenzhen, P. R. China.
Yanping LiDepartment of Ultrasound Medicine, South China Hospital, Medical School, Shenzhen University, Shenzhen, P. R. China.
Ting WangDepartment of Ultrasound Medicine, South China Hospital, Medical School, Shenzhen University, Shenzhen, P. R. China.
Xiaonan ChenDepartment of Urology, Shengjing Hospital of China Medical University, Shenyang, P. R. China. chenxn@cmu.edu.cn.
Wenjing ZhuMedical Research Department, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, P. R. China. zhuwj@uor.edu.cn.ORCID http://orcid.org/0000-0003-0958-0905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop an automatic segmentation model to delineate the adnexal masses and construct a machine learning model to differentiate between low malignant risk and intermediate-high malignant risk of adnexal masses based on ovarian-adnexal reporting and data system (O-RADS).

methodsA total of 663 ultrasound images of adnexal mass were collected and divided into two sets according to experienced radiologists: a low malignant risk set (n = 446) and an intermediate-high malignant risk set (n = 217). Deep learning segmentation models were trained and selected to automatically segment adnexal masses. Radiomics features were extracted utilizing a feature analysis system in Pyradiomics. Feature selection was conducted using the Spearman correlation analysis, Mann-Whitney U-test, and least absolute shrinkage and selection operator (LASSO) regression. A nomogram integrating radiomic and clinical features using a machine learning model was established and evaluated. The SHapley Additive exPlanations were used for model interpretability and visualization.

resultsThe FCN ResNet101 demonstrated the highest segmentation performance for adnexal masses (Dice similarity coefficient: 89.1%). Support vector machine achieved the best AUC (0.961, 95% CI: 0.925-0.996). The nomogram using the LightGBM algorithm reached the best AUC (0.966, 95% CI: 0.927-1.000). The diagnostic performance of the nomogram was comparable to that of experienced radiologists (p > 0.05) and outperformed that of less-experienced radiologists (p < 0.05). The model significantly improved the diagnostic accuracy of less-experienced radiologists.

conclusionsThe segmentation model serves as a valuable tool for the automated delineation of adnexal lesions. The machine learning model exhibited commendable classification capability and outperformed the diagnostic performance of less-experienced radiologists. CRITICAL RELEVANCE STATEMENT: The ultrasound radiomics-based machine learning model holds the potential to elevate the professional ability of less-experienced radiologists and can be used to assist in the clinical screening of ovarian cancer. KEY POINTS: We developed an image segmentation model to automatically delineate adnexal masses. We developed a model to classify adnexal masses based on O-RADS. The machine learning model has achieved commendable classification performance. The machine learning model possesses the capability to enhance the proficiency of less-experienced radiologists. We used SHapley Additive exPlanations to interpret and visualize the model.

Indexed as

Adnexal massDeep learningMachine learningSegmentationUltrasound

Identifiers

PMID39804536
PMCPMC11729609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.